Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1967 May;51(5):295–305. doi: 10.1136/bjo.51.5.295

Ocular melanosis with special reference to chlorpromazine.

M E Cameron
PMCID: PMC506388  PMID: 6022771

Full text

PDF
295

Images in this article

298Image
on p.298
299Image
on p.299
300Image
on p.300
300Image
on p.300
301Image
on p.301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYD F. J., Jr Chlorpromazine: ten years' experience. JAMA. 1963 Apr 6;184:51–54. doi: 10.1001/jama.1963.73700140004017. [DOI] [PubMed] [Google Scholar]
  2. BAUMANN H. Treten nach langdauernder und hochdosierter Largactiltherapie Schädigungen des Sehorgans auf? Anhang: Largactilmedikation in der Ophthalmologie. Klin Monbl Augenheilkd Augenarztl Fortbild. 1957;130(6):769–793. [PubMed] [Google Scholar]
  3. BOCK R., SWAIN J. OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY. Am J Ophthalmol. 1963 Nov;56:808–810. doi: 10.1016/0002-9394(63)92947-7. [DOI] [PubMed] [Google Scholar]
  4. CAIRNS R. J., CAPOORE H. S., GREGORY I. D. OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE. Lancet. 1965 Jan 30;1(7379):239–241. doi: 10.1016/s0140-6736(65)91524-2. [DOI] [PubMed] [Google Scholar]
  5. DELONG S. L., POLEY B. J., MCFARLANE J. R., Jr OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY. Arch Ophthalmol. 1965 May;73:611–617. doi: 10.1001/archopht.1965.00970030613003. [DOI] [PubMed] [Google Scholar]
  6. ENZIE F. D., WHITMORE G. E. Photosensitization keratitis in young goats following treatment with phenothiazine. J Am Vet Med Assoc. 1953 Sep;123(918):237–238. [PubMed] [Google Scholar]
  7. FELDMAN P. E., FRIERSON B. D. DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY. Am J Psychiatry. 1964 Aug;121:187–188. doi: 10.1176/ajp.121.2.187. [DOI] [PubMed] [Google Scholar]
  8. GREINER A. C., BERRY K. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. Can Med Assoc J. 1964 Mar 14;90:663–665. [PMC free article] [PubMed] [Google Scholar]
  9. Hobbs H. E., Eadie S. P., Somerville F. OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. Br J Ophthalmol. 1961 Apr;45(4):284–297. doi: 10.1136/bjo.45.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LLOYD L. A., HILTZ J. W. OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY. Can Med Assoc J. 1965 Mar 6;92:508–513. [PMC free article] [PubMed] [Google Scholar]
  11. SMITH J. L. Chloroquine macular degeneration. Arch Ophthalmol. 1962 Aug;68:186–190. doi: 10.1001/archopht.1962.00960030190009. [DOI] [PubMed] [Google Scholar]
  12. Satanove A. Pigmentation due to phenothiazines in high and prolonged dosage. JAMA. 1965 Jan 25;191(4):263–268. [PubMed] [Google Scholar]
  13. TUFFANELLI D., ABRAHAM R. K., DUBOIS E. I. PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS. Arch Dermatol. 1963 Oct;88:419–426. doi: 10.1001/archderm.1963.01590220051006. [DOI] [PubMed] [Google Scholar]
  14. ZELICKSON A. S., ZELLER H. C. A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE. JAMA. 1964 Apr 27;188:394–396. doi: 10.1001/jama.1964.03060300056018. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES